Zdrowie i gospodarka · 27/01/2000

FDA Plans to Develop Guidance on Electronic Submission of ANDA Archival Copies

The FDA's Office of Generic Drugs is developing guidance on submitting an electronic copy of a complete abbreviated new drug application (ANDA) in a format that can be archived, aiming to replace traditional paper submissions with electronic ones, and is soliciting public comments on its current program.